Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | MALT1 | Q9UDY8 | 3/20 | 0.36 |
| ▸ | GRM4 | Q14833 | 2/20 | 0.35 |
| ▸ | LIMK1 | P53667 | 2/20 | 0.35 |
| ▸ | LIMK2 | P53671 | 2/20 | 0.35 |
| ▸ | NTRK1 | P04629 | 4/20 | 0.35 |
| ▸ | DHODH | Q02127 | 1/20 | 0.35 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.35 |
| ▸ | IKBKB | O14920 | 1/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.33 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15971802 | 1.00 | ALDH1A1 (0.37) | ALDH1A1HPGDRAB9ASMN1; SMN2MALT1 | |
| SCHEMBL31060051 | 0.91 | LIMK1 (0.36) | ALDH1A1HPGDRAB9ASMN1; SMN2MALT1 | |
| SCHEMBL25274851 | 0.91 | TRPV1 (0.36) | MALT1LIMK1LIMK2DHODHPDE4B | |
| SCHEMBL15971748 | 0.90 | SLC2A1 (0.38) | MALT1LIMK1LIMK2DHODHPDE4B | |
| SCHEMBL31060079 | 0.90 | SLC2A1 (0.38) | MALT1LIMK1LIMK2DHODHPDE4B | |
| SCHEMBL15971617 | 0.90 | PSD (0.35) | SMN1; SMN2MALT1LIMK1LIMK2NTRK1 | |
| SCHEMBL15816514 | 0.89 | DHODH (0.35) | ALDH1A1MALT1GRM4LIMK1LIMK2 | |
| SCHEMBL31060012 | 0.87 | NTRK1 (0.38) | ALDH1A1HPGDRAB9ASMN1; SMN2MALT1 | |
| SCHEMBL15971848 | 0.87 | NTRK1 (0.38) | ALDH1A1HPGDRAB9ASMN1; SMN2MALT1 | |
| SCHEMBL15984455 | 0.86 | DHODH (0.44) | ALDH1A1HPGDRAB9ASMN1; SMN2MALT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240308988-A1 | Method For Controlling Diamide Resistant Pests and Compounds Therefor | SYNGENTA CROP PROTECTION AG (CH) | 2024-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240308988-A1 | Method For Controlling Diamide Resistant Pests and Compounds Therefor | DDT, NOS1, SLC11A2 | ALDH1A1 784/4885HPGD 2464/4885RAB9A 2456/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.